Clinical Trials Browser

OTHER × Smoldering Multiple Myeloma × atezolizumab × Clear all

NCT02784483 2020-03-03

Pilot Study Of Anti-Programmed Death Ligand-1 (Anti-PD-L1, Atezolizumab) In Asymptomatic Myeloma

Phase 1 Terminated

Smoldering Multiple Myeloma